Welcome to our dedicated page for DTRT news (Ticker: DTRT), a resource for investors and traders seeking the latest updates and insights on DTRT stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DTRT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DTRT's position in the market.
On January 30, 2023, stockholders of DTRT Health Acquisition Corp. (NASDAQ: DTRTU, DTRT, DTRTW) approved a Charter Amendment allowing the redemption of all issued Class A common stock before the current termination date of March 7, 2023. The Company will redeem shares due to the inability to complete a business combination by the new Amended Termination Date. This Mandatory Redemption is expected to occur around February 6, 2023, resulting in the dissolution and liquidation of the Company, with no redemption rights for warrants. The Company has notified Nasdaq for a trading suspension and intends to file a Form 25 for delisting.
DTRT Health Acquisition Corp. announced the adjournment of its special meeting of stockholders from December 1, 2022, to December 6, 2022, at 3:00 p.m. Central Time, to allow more time for the amendment of its certificate of incorporation. This amendment extends the deadline for completing a business combination until March 7, 2023. The record date for voting remains October 24, 2022. Stockholders who voted previously need not act again, though those on the record date can still cast their votes regardless of share sales.
Consumer Direct Holdings, Inc. (CDH) and DTRT Health Acquisition Corp. (DTRT) announced the filing of a Registration Statement with the SEC regarding their proposed business combination. A merger agreement was signed on September 28, 2022, with completion expected in Q1 2023, subject to stockholder approval and regulatory clearance. The transaction values CDH at approximately $691 million. Post-merger, the new entity, expected to be called Consumer Direct Care Network, Inc., will trade under new stock symbols on Nasdaq.
Consumer Direct Holdings (CDH) and DTRT Health Acquisition Corp (DTRT) have announced a definitive merger deal, positioning CDH to become a public company with an enterprise valuation of
FAQ
What is the market cap of DTRT (DTRT)?
